Stryker in Advanced Talks to Acquire Inari Medical - Reuters

Investing.com -- Medical device manufacturer Stryker is reportedly in the final stages of negotiations to acquire Inari Medical, a company that produces devices for the treatment of venous diseases. This rumor was published on Monday based on anonymous sources familiar with the matter.

If the talks are successful, an announcement regarding the acquisition could be made within this week. The acquisition of Inari Medical, which has a market value approaching approximately $3 billion, would expand Stryker’s portfolio and enhance treatment options for venous thromboembolism (a condition characterized by clotting in blood vessels) and other venous diseases.

In recent weeks, Inari had been considering a sale due to acquisition interest from Stryker and other parties. Sources noted that another potential buyer could still approach Inari, and there is a possibility that no agreement may be reached with any interested parties.